Activation of the wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models

Academic Article


  • Although Wnt signaling is known to mediate multiple biological and pathological processes, its association with diabetic retinopathy (DR) has not been established. Here we show that retinal levels and nuclear translocation of β-catenin, a key effector in the canonical Wnt pathway, were increased in humans with DR and in three DR models. Retinal levels of lowdensity lipoprotein receptor-related proteins 5 and 6, coreceptors of Wnts, were also elevated in the DR models. The high glucose-induced activation of β-catenin was attenuated by aminoguanidine, suggesting that oxidative stress is a direct cause for the Wnt pathway activation in diabetes. Indeed, Dickkopf homolog 1, a specific inhibitor of the Wnt pathway, ameliorated retinal inflammation, vascular leakage, and retinal neovascularization in the DR models. Dickkopf homolog 1 also blocked the generation of reactive oxygen species induced by high glucose, suggesting that Wnt signaling contributes to the oxidative stress in diabetes. These observations indicate that the Wnt pathway plays a pathogenic role in DR and represents a novel therapeutic target. Copyright © American Society for Investigative Pathology.
  • Authors

    Published In

    Digital Object Identifier (doi)

    Pubmed Id

  • 26084201
  • Author List

  • Chen Y; Hu Y; Zhou T; Zhou KK; Mott R; Wu M; Boulton M; Lyons TJ; Gao G; Ma JX
  • Start Page

  • 2676
  • End Page

  • 2685
  • Volume

  • 175
  • Issue

  • 6